cart

0.00
HPLC testedCOA every batchEU shippingSEPA · secure paymentResearch Use Only
PEPTIQA BIOTECHSemax10 mgPurity 98.5% · RUO

Excellent

Rating 4.8 / 5 — early quality score

Peptiqa Reviews

Early quality score — buyers can leave a review after verified purchase.

Semax

10 mg98.5% purityLot #SEMAX-2026-001

SKU of selected dimension: PEP-SEMAX-10MG

Semax is a synthetic nootropic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH 4-10), enhanced with a Pro-Gly-Pro sequence to improve both stability and bioavailability. Originally developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, Semax has been approved in Russia and Ukraine as a prescription medication for stroke rehabilitation, cognitive dysfunction, and peptic ulcer disease. Its primary mechanism centers on the substantial upregulation of BDNF (Brain-Derived Neurotrophic Factor), a critical protein involved in neuronal growth, survival, and synaptic plasticity. Research published in Neuroscience Letters has shown that Semax can increase BDNF mRNA expression by up to six-fold, contributing to enhanced memory formation, cognitive performance, and neuroprotection.
€70.76incl. VAT
In Stock (40)

Volume pricing

QuantityUnit priceSavings
1 vial70.76
3 vials (−7%)65.88−7%
5 vials (−12%)62.22−12%
Purchase & earn 58 points!

Ratings & reviews

Log in to rate this product after your order arrives. login

Certificate of Analysis

Lab Verified
View certificate before purchase — transparency guaranteed
Research Profile

Semaxscientific profile

Content is for educational and research purposes. Research Use Only.

  • Semax is a synthetic nootropic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH 4-10), enhanced with a Pro-Gly-Pro sequence to improve both stability and bioavailability. Originally developed at the Institute of Molecular Genetics of the Russian Academy of Sciences, Semax has been approved in Russia and Ukraine as a prescription medication for stroke rehabilitation, cognitive dysfunction, and peptic ulcer disease.
  • Its primary mechanism centers on the substantial upregulation of BDNF (Brain-Derived Neurotrophic Factor), a critical protein involved in neuronal growth, survival, and synaptic plasticity. Research published in Neuroscience Letters has shown that Semax can increase BDNF mRNA expression by up to six-fold, contributing to enhanced memory formation, cognitive performance, and neuroprotection.

More from Nootropiki

This site uses cookies

Accept